STOCK TITAN
  1. Home
  2. Sec-filings
  3. PGY
  4. [Form 4] Pagaya Technologies Ltd. Insider Trading Activity

PGY insider sale: 15,026 shares disposed at $29.90–$32.62 under 10b5-1

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Pagaya Technologies Ltd. (PGY) Form 4 shows that Tami Rosen, identified as a Director and Chief Development Officer, sold 15,026 Class A ordinary shares on 10/01/2025 at a weighted average price of $30.7345 per share under a 10b5-1 plan. After the transactions, the filing reports she beneficially owns 28,181 Class A shares.

The filing notes the sale occurred in multiple transactions with prices ranging from $29.90 to $32.62 and that the reporting person will provide details of per-price amounts on request. The Form 4 was signed by an attorney-in-fact on 10/03/2025.

Positive

  • Sale executed under a 10b5-1 plan, indicating it was pre-arranged
  • Full price range disclosed ($29.90–$32.62) with offer to provide per-price details on request
  • Form 4 filed for an officer/director, fulfilling Section 16 disclosure obligations

Negative

  • Insider disposed of 15,026 Class A shares, reducing beneficial ownership to 28,181
  • Weighted average sale price $30.7345 may represent a material liquidity event for this insider holding

Insights

Insider sold 15,026 shares via a pre-arranged 10b5-1 plan.

The sale of 15,026 shares at a weighted average of $30.7345 reduces reported beneficial ownership to 28,181 shares, which is an explicit, documented change in insider holdings.

Because the sale was executed under a 10b5-1 plan, it indicates pre-planned disposition rather than ad-hoc trading; the filer discloses the price range of $29.90–$32.62 and offers to supply per-price breakdowns on request.

Officer and director compliance appears documented and signed by attorney-in-fact.

The Form 4 identifies the reporting person as both a Director and Chief Development Officer, and shows the submission was executed by an attorney-in-fact, with the signature block dated 10/03/2025.

This filing provides the required disclosure of insider disposition and the 10b5-1 plan notice, meeting Section 16 reporting obligations shown in the form.

Insider Rosen Tami
Role Chief Development Officer
Sold 15,026 shs ($462K)
Type Security Shares Price Value
Sale Class A Ordinary Share 15,026 $30.7345 $462K
Holdings After Transaction: Class A Ordinary Share — 28,181 shares (Direct)
Footnotes (1)
  1. This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information. Weighted average price. These shares were sold in multiple transactions at prices ranging from $29.90 to $32.62 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rosen Tami
(Last) (First) (Middle)
C/O PAGAYA TECHNOLOGIES LTD.
335 MADISON AVENUE, 16TH FLOOR
(Street)
NEW YORK NY 10017
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Pagaya Technologies Ltd. [ PGY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Development Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Ordinary Share 10/01/2025 10/01/2025 S(1) 15,026 D $30.7345(2) 28,181 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.
2. Weighted average price. These shares were sold in multiple transactions at prices ranging from $29.90 to $32.62 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Remarks:
/s/ Natalie Wilmore, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Pagaya insider Tami Rosen report on Form 4 (PGY)?

The filing reports a sale of 15,026 Class A shares on 10/01/2025, executed under a 10b5-1 plan, at a weighted average price of $30.7345, leaving 28,181 shares beneficially owned.

Was the sale by the insider pre-planned or ad-hoc for PGY?

The Form 4 explicitly states the sale was effected pursuant to a 10b5-1 plan, indicating a pre-arranged trading plan.

What price range did the insider sale cover for PGY shares?

The filer disclosed the shares were sold at prices ranging from $29.90 to $32.62 and offered to provide per-price amounts on request.

Who signed the Form 4 for Tami Rosen's transaction?

The Form 4 was signed by Natalie Wilmore, Attorney-in-Fact on 10/03/2025.

What roles does the reporting person hold at Pagaya (PGY)?

The filing lists the reporting person as a Director and as an Officer with the title Chief Development Officer.